Clinical Trial Update: Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study [Phase 2]

View source ↗

Summary

This Phase 2 feasibility trial is evaluating IL-6-guided treatment using dexamethasone or tocilizumab in hospitalized patients with acute hypoxemic respiratory …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxemic Respiratory Failure

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Tocilizumab (tocilizumab)

Snippet

Sponsor: Lorenzo delSorbo | Conditions: Acute Hypoxemic Respiratory Failure | Phase 2 | Status: RECRUITING